drugset / Trial / NCT06919796

mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

NCT06919796

Phase 2 Not yet recruiting 40 enrolled PharmaJet, Inc. Emory University · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if immune responses differ when the mRNA COVID-19 vaccine is given through different delivery methods, including a needle-free injection system, or via intramuscular injection using needle and syringe

Timeline

Start
2025-05-01
Primary completion
2026-05-01
Completion
2026-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject BNT162b2 Messenger RNA (mRNA) Intramuscular